243 related articles for article (PubMed ID: 38660357)
1. Screening for social determinants of health among populations at risk for MASLD: a scoping review.
Kim RG; Ballantyne A; Conroy MB; Price JC; Inadomi JM
Front Public Health; 2024; 12():1332870. PubMed ID: 38660357
[TBL] [Abstract][Full Text] [Related]
2. Racial and ethnic differences and the role of unfavorable social determinants of health across steatotic liver disease subtypes in the United States.
Ochoa-Allemant P; Marrero JA; Serper M
Hepatol Commun; 2023 Dec; 7(12):. PubMed ID: 38051551
[TBL] [Abstract][Full Text] [Related]
3. Effects of social determinants of health on mortality and incident liver-related events and cardiovascular disease in steatotic liver disease.
Chen VL; Song MW; Suresh D; Wadhwani SI; Perumalswami P
Aliment Pharmacol Ther; 2023 Sep; 58(5):537-545. PubMed ID: 37394976
[TBL] [Abstract][Full Text] [Related]
4. Social determinants of health and cancer screening implementation and outcomes in the USA: a systematic review protocol.
Korn AR; Walsh-Bailey C; Pilar M; Sandler B; Bhattacharjee P; Moore WT; Brownson RC; Emmons KM; Oh AY
Syst Rev; 2022 Jun; 11(1):117. PubMed ID: 35676720
[TBL] [Abstract][Full Text] [Related]
5. Emergency department-based interventions affecting social determinants of health in the United States: A scoping review.
Walter LA; Schoenfeld EM; Smith CH; Shufflebarger E; Khoury C; Baldwin K; Hess J; Heimann M; Crosby C; Sontheimer SY; Gragg S; Hand D; McIlwain J; Greene C; Skains RM; Hess EP
Acad Emerg Med; 2021 Jun; 28(6):666-674. PubMed ID: 33368833
[TBL] [Abstract][Full Text] [Related]
6. Evidence related to a vegetarian diet and metabolic dysfunction-associated steatotic liver disease: protocol for a scoping review.
Moss K; Gitman V; Pinto Sanchez MI; Oczkowski S; Armstrong D; Jayakumar S; Karvellas CJ; Selzner N; Dionne J
BMJ Open; 2024 Apr; 14(4):e079750. PubMed ID: 38604643
[TBL] [Abstract][Full Text] [Related]
7. An Integrative Review of Social Determinants of Health Assessment and Screening Tools Used in Pediatrics.
Morone J
J Pediatr Nurs; 2017; 37():22-28. PubMed ID: 28811057
[TBL] [Abstract][Full Text] [Related]
8. Food insecurity is a risk factor for metabolic dysfunction-associated steatotic liver disease in Latinx children.
Maxwell SL; Price JC; Perito ER; Rosenthal P; Wojcicki JM
Pediatr Obes; 2024 Jun; 19(6):e13109. PubMed ID: 38453472
[TBL] [Abstract][Full Text] [Related]
9. Utilising clinical settings to identify and respond to the social determinants of health of individuals with type 2 diabetes-A review of the literature.
Frier A; Devine S; Barnett F; Dunning T
Health Soc Care Community; 2020 Jul; 28(4):1119-1133. PubMed ID: 31852028
[TBL] [Abstract][Full Text] [Related]
10. Association of Metabolic Dysfunction-Associated Steatotic Liver Disease/Non-alcoholic Fatty Liver Disease With Type 2 Diabetes Mellitus: A Case-Control Study in a Tertiary Care Hospital in Pakistan.
Zahoor F; Saeed NU; Javed S; Sadiq HZ; Mand Khan F; Haider M; Shafqat MN; Maqbool A; Chaudhry A
Cureus; 2023 Oct; 15(10):e47240. PubMed ID: 38021965
[TBL] [Abstract][Full Text] [Related]
11. Scoping Review of Screening and Assessment Tools for Social Determinants of Health in the Field of Cardiovascular Disease.
Suzuki T; Mizuno A; Yasui H; Noma S; Ohmori T; Rewley J; Kawai F; Nakayama T; Kondo N; Tsukada YT
Circ J; 2024 Feb; 88(3):390-407. PubMed ID: 38072415
[TBL] [Abstract][Full Text] [Related]
12. Inclusion of Social and Structural Determinants of Health to Advance Understanding of their Influence on the Biology of Chronic Disease.
Emeny RT; Zhang K; Goodman D; Dev A; Lewinson T; Wolff K; Kerrigan CL; Kraft S
Curr Protoc; 2022 Oct; 2(10):e556. PubMed ID: 36200800
[TBL] [Abstract][Full Text] [Related]
13. Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease.
Younossi ZM; Paik JM; Stepanova M; Ong J; Alqahtani S; Henry L
J Hepatol; 2024 May; 80(5):694-701. PubMed ID: 38286339
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 Studies.
Chan KE; Ong EYH; Chung CH; Ong CEY; Koh B; Tan DJH; Lim WH; Yong JN; Xiao J; Wong ZY; Syn N; Kaewdech A; Teng M; Wang JW; Chew N; Young DY; Know A; Siddiqui MS; Huang DQ; Tamaki N; Wong VW; Mantzoros CS; Sanyal A; Noureddin M; Ng CH; Muthiah M
Clin Gastroenterol Hepatol; 2024 Mar; 22(3):488-498.e14. PubMed ID: 37775028
[TBL] [Abstract][Full Text] [Related]
15. Metabolic dysfunction-associated steatotic liver disease in older adults is associated with frailty and social disadvantage.
Clayton-Chubb D; Kemp WW; Majeed A; Lubel JS; Woods RL; Tran C; Ryan J; Hodge A; Schneider HG; McNeil JJ; Roberts SK
Liver Int; 2024 Jan; 44(1):39-51. PubMed ID: 37698034
[TBL] [Abstract][Full Text] [Related]
16. Update in lean metabolic dysfunction-associated steatotic liver disease.
Sato-Espinoza K; Chotiprasidhi P; Huaman MR; Díaz-Ferrer J
World J Hepatol; 2024 Mar; 16(3):452-464. PubMed ID: 38577539
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of hospital and health system initiatives to address social determinants of health in the United States: a scoping review of the peer-reviewed literature.
Rangachari P; Thapa A; Sherpa DL; Katukuri K; Ramadyani K; Jaidi HM; Goodrum L
Front Public Health; 2024; 12():1413205. PubMed ID: 38873294
[TBL] [Abstract][Full Text] [Related]
18. Collection and Use of Social Determinants of Health Data in Inpatient General Internal Medicine Wards: A Scoping Review.
Davis VH; Rodger L; Pinto AD
J Gen Intern Med; 2023 Feb; 38(2):480-489. PubMed ID: 36471193
[TBL] [Abstract][Full Text] [Related]
19. Guideline-based management of metabolic dysfunction-associated steatotic liver disease in the primary care setting.
Allen AM; Charlton M; Cusi K; Harrison SA; Kowdley KV; Noureddin M; Shubrook JH
Postgrad Med; 2024 Apr; 136(3):229-245. PubMed ID: 38465573
[TBL] [Abstract][Full Text] [Related]
20. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]